Literature DB >> 7306028

Purification and physicochemical characterization of a human cytotoxic factor produced by a human haemic cell line.

H Neumann, A Karpas.   

Abstract

A cytotoxic factor, produced by a human lymphoblastoid cell line [Karpas (1977) Br. J. Cancer 35, 152--160; Karpas (1977) Br. J. Cancer 36, 437--445], was purified both from the cell extracts and from the culture medium containing the cell lysate, by using ammonium sulphate precipitation, DEAE-cellulose chromatography, gel filtration and affinity chromatography on concanavalin A--Sepharose and on [3H]amino-ethanol--glass beads. Two factors, Factor I and Factor II, were separated by DEAE-cellulose chromatography. Factor I was eluted from this column at 30 mM-aminoethanol/HCl buffer, pH 8.0, whereas Factor II was bound strongly to DEAE-cellulose and was eluted only at 325 mM-aminoethanol/HCl buffer, pH 8.0. The purified Factor I migrated as a single band on polyacrylamide-gel electrophoresis. Its isoelectric point, pI, was 8.0 +/- 0.3. Its sedimentation coefficient, S20,w, was 3.5 +/- 0.1 S and its apparent molecular weight, Mr, was 65 000 +/- 1000 as determined by sedimentation-velocity and sedimentation-equilibrium measurements. A linear relationship between molecular weight and concentration was found in equilibrium runs, suggesting a non-spherical shape of the molecule. Factor I is not a glycoprotein, inasmuch as it does not bind to concanavalin A--Sepharose. It consists of two subunits (Mr 32 000 +/- 4000), migrating on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis as a single band. Factor II had pI 6.0 +/- 0.4 and Mr 75 000 +/- 3000. Factors I and II are thus different proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306028      PMCID: PMC1162821          DOI: 10.1042/bj1940847

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

Review 1.  Lymphocyte effector molecules and cell-mediated immune reactions.

Authors:  G A Granger; R A Daynes; P E Runge; A M Prieur; E W Jeffes
Journal:  Contemp Top Mol Immunol       Date:  1975

2.  PURIFICATION, COMPOSITION, AND MOLECULAR WEIGHT OF THE BETA-GALACTOSIDASE OF ESCHERICHIA COLI K12.

Authors:  G R CRAVEN; E STEERS; C B ANFINSEN
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

3.  Some experimental factors in the gradient chromatography of serum proteins.

Authors:  E A PETERSON; E A CHIAZZE
Journal:  Arch Biochem Biophys       Date:  1962-10       Impact factor: 4.013

4.  Rapid determination of molecular weights of peptides and preteins.

Authors:  D A YPHANSTIS
Journal:  Ann N Y Acad Sci       Date:  1960-08-31       Impact factor: 5.691

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Hydrolysis of S-substituted monoesters of phosphorothioic acid by alkaline phosphatase from Escherichia coli.

Authors:  H Neumann; L Boross; E Katchalski
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

7.  Activated macrophages kill tumour cells by releasing arginase.

Authors:  G A Currie
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

8.  A cytotoxic proteinase isolated from human lymphocytes.

Authors:  V B Hatcher; M S Oberman; G S Lazarus; A I Grayzel
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

9.  A human haemic cell line capable of cellular and humoral killing of normal and malignant cells.

Authors:  A Karpas
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

10.  A humoral cytotoxic substance produced by a human killer cell line.

Authors:  A Karpas
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

View more
  1 in total

1.  Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

Authors:  H I Yamanaka; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.